165 related articles for article (PubMed ID: 21192859)
1. Serodiagnosis of primary infections with human parvovirus 4, Finland.
Lahtinen A; Kivelä P; Hedman L; Kumar A; Kantele A; Lappalainen M; Liitsola K; Ristola M; Delwart E; Sharp C; Simmonds P; Söderlund-Venermo M; Hedman K
Emerg Infect Dis; 2011 Jan; 17(1):79-82. PubMed ID: 21192859
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
4. Low Prevalence of Parvovirus 4 in HIV-infected Children in Denmark.
Rosenfeldt V; Norja P; Lindberg E; Jensen L; Hedman L; Väisänen E; Li X; Hedman K; von Linstow ML
Pediatr Infect Dis J; 2015 Jul; 34(7):761-2. PubMed ID: 25545184
[TBL] [Abstract][Full Text] [Related]
5. Absence of novel human parvovirus (PARV4) in Danish mothers and children.
von Linstow ML; Rosenfeldt V; Lindberg E; Jensen L; Hedman L; Li X; Väisänen E; Hedman K; Norja P
J Clin Virol; 2015 Apr; 65():23-5. PubMed ID: 25766982
[TBL] [Abstract][Full Text] [Related]
6. Molecular and serological assessment of parvovirus B-19 infection in Egyptian children with sickle cell disease.
Makhlouf MM; Elwakil SG; Ibrahim NS
J Microbiol Immunol Infect; 2017 Oct; 50(5):565-569. PubMed ID: 26698686
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic tests: Human parvovirus B19].
Nunoue T
Nihon Rinsho; 2005 Jul; 63 Suppl 7():329-31. PubMed ID: 16111265
[No Abstract] [Full Text] [Related]
8. Human parvovirus 4 infection among mothers and children in South Africa.
Matthews PC; Sharp CP; Malik A; Gregory WF; Adland E; Jooste P; Goulder PJ; Simmonds P; Klenerman P
Emerg Infect Dis; 2015 Apr; 21(4):713-5. PubMed ID: 25812109
[No Abstract] [Full Text] [Related]
9. Low prevalence of active parvovirus B19 infection in HIV-infected patients.
Raguin G; Leruez-Ville M; Gregoire V; Deplanche M; Leport C; Morinet F; Vilde JL
Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):760-2. PubMed ID: 9405950
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.
Norja P; Hedman L; Kantola K; Kemppainen K; Suvilehto J; Pitkäranta A; Aaltonen LM; Seppänen M; Hedman K; Söderlund-Venermo M
J Med Virol; 2012 Aug; 84(8):1267-73. PubMed ID: 22711355
[TBL] [Abstract][Full Text] [Related]
11. Serodiagnosis of human bocavirus infection.
Kantola K; Hedman L; Allander T; Jartti T; Lehtinen P; Ruuskanen O; Hedman K; Söderlund-Venermo M
Clin Infect Dis; 2008 Feb; 46(4):540-6. PubMed ID: 18199037
[TBL] [Abstract][Full Text] [Related]
12. Parvovirus 4 infection and clinical outcome in high-risk populations.
Simmons R; Sharp C; McClure CP; Rohrbach J; Kovari H; Frangou E; Simmonds P; Irving W; Rauch A; Bowness P; Klenerman P;
J Infect Dis; 2012 Jun; 205(12):1816-20. PubMed ID: 22492853
[TBL] [Abstract][Full Text] [Related]
13. Epidemiologic study of human parvovirus B19 infection in East China.
Zhang L; Cai C; Pan F; Hong L; Luo X; Hu S; Xu J; Chen Z
J Med Virol; 2016 Jul; 88(7):1113-9. PubMed ID: 26705119
[TBL] [Abstract][Full Text] [Related]
14. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
Sharp CP; Lail A; Donfield S; Simmons R; Leen C; Klenerman P; Delwart E; Gomperts ED; Simmonds P
J Infect Dis; 2009 Oct; 200(7):1119-25. PubMed ID: 19691429
[TBL] [Abstract][Full Text] [Related]
15. Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV.
Azadmanesh K; Mohraz M; Kazemimanesh M; Aghakhani A; Foroughi M; Banifazl M; Eslamifar A; Ramezani A
J Med Virol; 2015 Jul; 87(7):1124-9. PubMed ID: 25771750
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.
van Elsacker-Neile AM; Kroon FP; van der Ende ME; Salimans MM; Spaan WJ; Kroes AC
Clin Infect Dis; 1996 Dec; 23(6):1255-60. PubMed ID: 8953068
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
[TBL] [Abstract][Full Text] [Related]
18. Human parvovirus 4 as potential cause of encephalitis in children, India.
Benjamin LA; Lewthwaite P; Vasanthapuram R; Zhao G; Sharp C; Simmonds P; Wang D; Solomon T
Emerg Infect Dis; 2011 Aug; 17(8):1484-7. PubMed ID: 21801629
[TBL] [Abstract][Full Text] [Related]
19. A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa Population Study (KOPS).
Ihara T; Furusyo N; Hayashi T; Toyoda K; Murata M; Hayashi J
Arch Virol; 2013 Dec; 158(12):2465-72. PubMed ID: 23775357
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus B19 antibodies in immunocompromized children in Thailand.
Suandork P; Theamboonlers A; Likitnukul S; Hirsch P; Poovorawan Y
Asian Pac J Allergy Immunol; 2000 Sep; 18(3):161-4. PubMed ID: 11270472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
